E-ISSN: 2619-9467

Contents    Cover    Publication Date: 20 Sep 2023
Year 2023 - Volume 33 - Issue 3

Open Access

Peer Reviewed

869 Viewed840 Downloaded

The Relationship Between the Number of Miscarriages and Diagnostic Parameters in Couples with Recurrent Pregnancy Loss: A Retrospective Cohort Study

Full Text PDF  
JCOG. 2023;33(3):143-50
DOI: 10.5336/jcog.2023-95397
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Objective: The aim of this study was to compare the ovarian reserve tests and abnormal test results in couples with 2 to more than 2 recurrent pregnancy losses in our population. Material and Methods: Seventy-five couples aged 20-44 years, who had two or more consecutive abortions at 20 weeks or less from the last menstrual period, were included in the study. The women were divided into two groups as those who had two miscarriages (Group 1, n=34) and those who had three or more miscarriages (Group 2, n=41). Women in both groups were compared in terms of serum hormone levels, biochemical parameters, karyotype analysis, thrombophilic, and uterine factors. The spermiogram values and karyotype analyzes of the male partners in both groups were compared. Results: The women in Group 2 were older than those in Group 1, and live birth history and Factor V Leiden heterozygosity were found to be statistically significantly higher. The follicle stimulating hormone values in the secondary recurrent pregnancy loss patients were found to be statistically significantly higher than in the primary recurrent pregnancy loss patients. Conclusion: Maternal age and Factor V Leiden heterozygosity may be associated with the number of miscarriages in couples with recurrent pregnancy loss.
  1. de Ziegler D, Frydman RF. Recurrent pregnancy losses, a lasting cause of infertility. Fertil Steril. 2021;115(3):531-2. [Crossref]  [PubMed] 
  2. Sugiura-Ogasawara M. Recurrent pregnancy loss and obesity. Best Pract Res Clin Obstet Gynaecol. 2015;29(4):489-97. [Crossref]  [PubMed] 
  3. Regan L, Backos M, Rai R. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG Green-top Guideline No. 17. 2010. [Link] 
  4. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-11. [Crossref]  [PubMed] 
  5. Musters AM, Koot YE, van den Boogaard NM, Kaaijk E, Macklon NS, van der Veen F, et al. Supportive care for women with recurrent miscarriage: a survey to quantify women's preferences. Hum Reprod. 2013;28(2):398-405. [Crossref]  [PubMed] 
  6. ESHRE Guideline Group on RPL; Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):hoy004. [Crossref]  [PubMed]  [PMC] 
  7. Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91(1073):151-62. [Crossref]  [PubMed] 
  8. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. Obstet Gynecol. 2018;132(1):e18-e34. Erratum in: Obstet Gynecol. 2018;132(4):1069. [Crossref]  [PubMed] 
  9. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63. [Crossref]  [PubMed] 
  10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. [Crossref]  [PubMed] 
  11. Demko ZP, Simon AL, McCoy RC, Petrov DA, Rabinowitz M. Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening. Fertil Steril. 2016;105(5):1307-13. [Crossref]  [PubMed] 
  12. Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. [Crossref]  [PubMed]  [PMC] 
  13. Wald KA, Shahine LK, Lamb JD, Marshall LA, Hickok LR. High incidence of diminished ovarian reserve in young unexplained recurrent pregnancy loss patients. Gynecol Endocrinol. 2020;36(12):1079-81. [Crossref]  [PubMed] 
  14. Han AR, Han JW, Lee SK. Inherited thrombophilia and anticoagulant therapy for women with reproductive failure. Am J Reprod Immunol. 2021;85(4):e13378. [Crossref]  [PubMed] 
  15. Nahas R, Saliba W, Elias A, Elias M. The prevalence of thrombophilia in women with recurrent fetal loss and outcome of anticoagulation therapy for the prevention of miscarriages. Clin Appl Thromb Hemost. 2018;24(1):122-8. [Crossref]  [PubMed]  [PMC] 
  16. D'Uva M, Micco PD, Strina I, Placido GD. Recurrent pregnancy loss and thrombophilia. J Clin Med Res. 2010;2(1):18-22. [PubMed]  [PMC] 
  17. Mierla D, Szmal C, Neagos D, Cretu R, Stoian V, Jardan D. Association of prothrombin (A20210G) and factor V Leiden (A506G) with recurrent pregnancy loss. Maedica (Bucur). 2012;7(3):222-6. [PubMed]  [PMC] 
  18. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006;55(5):360-8. [Crossref]  [PubMed] 
  19. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med. 2006;24(1):54-66. [Crossref]  [PubMed] 
  20. Ivanov P, Tsvyatkovska T, Konova E, Komsa-Penkova R. Inherited thrombophilia and IVF failure: the impact of coagulation disorders on implantation process. Am J Reprod Immunol. 2012;68(3):189-98. [Crossref]  [PubMed] 
  21. Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, et al. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome. Lupus. 2018;27(10):1679-86. [Crossref]  [PubMed] 
  22. Alecsandru D, Klimczak AM, Garcia Velasco JA, Pirtea P, Franasiak JM. Immunologic causes and thrombophilia in recurrent pregnancy loss. Fertil Steril. 2021;115(3):561-6. [Crossref]  [PubMed] 
  23. ACOG Practice Bulletin No. 118: antiphospholipid syndrome. Obstet Gynecol. 2011;117(1):192-9. [Crossref]  [PubMed] 
  24. Parveen F, Tuteja M, Agrawal S. Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women. Arch Gynecol Obstet. 2013;288(5):1171-7. [Crossref]  [PubMed] 
  25. Klimczak AM, Patel DP, Hotaling JM, Scott RT Jr. Role of the sperm, oocyte, and embryo in recurrent pregnancy loss. Fertil Steril. 2021;115(3):533-7. [Crossref]  [PubMed] 
  26. Franssen MT, Korevaar JC, van der Veen F, Leschot NJ, Bossuyt PM, Goddijn M. Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index [corrected]-control study. BMJ. 2006;332(7544):759-63. Erratum in: BMJ. 2006;332(7548):1012. [Crossref]  [PubMed]  [PMC] 
  27. Barber JC, Cockwell AE, Grant E, Williams S, Dunn R, Ogilvie CM. Is karyotyping couples experiencing recurrent miscarriage worth the cost? BJOG. 2010;117(7):885-8. [Crossref]  [PubMed] 
  28. Carbonnel M, Pirtea P, de Ziegler D, Ayoubi JM. Uterine factors in recurrent pregnancy losses. Fertil Steril. 2021;115(3):538-45. [Crossref]  [PubMed] 
  29. Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum Reprod Update. 2011;17(6):761-71. [Crossref]  [PubMed]  [PMC] 
  30. van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, van Wely M, et al. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update. 2020;26(3):356-67. [Crossref]  [PubMed]  [PMC] 
  31. Isaoglu U, Ulug P, Delibas IB, Yilmaz M, Kumtepe Y, Dogan H, et al. The association between inherited thrombophilia and recurrent pregnancy loss in Turkish women. Clin Exp Obstet Gynecol. 2014;41(2):177-81. [Crossref]  [PubMed] 
  32. Yengel I, Yorulmaz T, Api M. Association between FVL G1691A, FII G20210A, and MTHFR C677T and A1298C polymorphisms and Turkish women with recurrent pregnancy loss. Med Glas (Zenica). 2020;17(1):129-35. [PubMed] 
  33. Yildiz G, Yavuzcan A, Yildiz P, Süer N, Tandoğan N. Inherited thrombophilia with recurrent pregnancy loss in Turkish women--a real phenomenon? Ginekol Pol. 2012;83(8):598-603. [PubMed] 
  34. Aksoy M, Tek I, Karabulut H, Berker B, Soylemez F. The role of thrombofilia related to Factor V Leiden and Factor II G20210A mutations in recurrent abortions. J Pak Med Assoc. 2005;55(3):104-8. [PubMed] 
  35. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007;86(10):727-31. [Crossref]  [PubMed]